Peer-reviewedCC BYFrontiers in immunology
Eculizumab in rapidly progressive glomerulonephritis: a case-series report
- 1Department of Nephrology, The Second Affiliated Hospital of Nanchang University , , ,
Related
- [Eculizumab resistance caused by C5 gene polymorphism in a patient with paroxysmal nocturnal hemoglobinuria: a case report].
- ANCA-Negative Pauci-immune Necrotizing Glomerulonephritis: A Case Series and a New Clinical Classification
- Case Report: CD20/BCMA bispecific CAR-T therapy for progressive multiple sclerosis
- Oral Upadacitinib Combined with Phototherapy for Progressive Vitiligo in 7-Year-Old Children: A Two-Case Report.
- Case report: Progressive organ-threatening IgG4-related disease despite conventional immunosuppression: lessons from a 5-year longitudinal follow-up
BibTeX
@article{li2026eculizumab,
title = {{Eculizumab in rapidly progressive glomerulonephritis: a case-series report}},
author = {Xueting Li and Yinghui Zhang and Ben Ke},
journal = {Frontiers in immunology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13655034},
note = {CC BY},
}
RIS
TY - JOUR
TI - Eculizumab in rapidly progressive glomerulonephritis: a case-series report
AU - Xueting Li
AU - Yinghui Zhang
AU - Ben Ke
PY - 2026
DA - 2026/10/16
JO - Frontiers in immunology
UR - https://europepmc.org/article/PMC/PMC13655034
SN - 1664-3224
ER -